correlation of urine albumin/creatinine ratio (uacr), high sensitivity c-reactive protein (hscrp) and n-terminal pro brain natriuretic peptide (nt-probnp) with atherosclerosis (oxldl) in centrally obese men

Clicks: 290
ID: 248567
2011
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
BACKGROUND: Obesity is closely associated with atherosclerosis risk and cardiovascular disease. Novel cardiovascular risk biomarkers such as Urine Albumin/Creatinine Ratio (UACR), High Sensitivity C-Reactive Protein (hsCRP) and N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) have been observed to predict cardiovascular disease in the general population. The aim of this study was to observe the correlation of UACR, hsCRP and NT-proBNP with atherosclerosis (OxLDL) in centrally obese men. METHODS: The study was observational with a cross sectional design done on 76 male subjects aged 30–50 years with central obesity and mean of age of 37 years. Urine albumin was determined by PEG enhanced immunoturbidimetric assay, urine creatinine by Jaffe without deproteinase, hsCRP by chemiluminescent immunometric assay, NT-proBNP by electrochemiluminescence (ECLIA) and OxLDL by ELISA. RESULTS: There was significant correlation between hsCRP and OxLDL (r=0.230, p=0.046). There was no significant correlation between UACR and OxLDL (r=-0.138, p=0.236), neither between Log NT-proBNP and OxLDL (r=-0.173, p=0.136). CONCLUSIONS: Atherosclerosis was significantly correlated with hsCRP (low grade inflammation). KEYWORDS: NT-proBNP, UACR, hsCRP, OxLDL, atherosclerosis.
Reference Key
pakpahan2011indonesiancorrelation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Nancy Pakpahan;Mansyur Arif;Ilhamjaya Patellongi
Journal a companion to american indie film
Year 2011
DOI 10.18585/inabj.v3i1.132
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.